JP2023545046A5 - - Google Patents

Info

Publication number
JP2023545046A5
JP2023545046A5 JP2023521100A JP2023521100A JP2023545046A5 JP 2023545046 A5 JP2023545046 A5 JP 2023545046A5 JP 2023521100 A JP2023521100 A JP 2023521100A JP 2023521100 A JP2023521100 A JP 2023521100A JP 2023545046 A5 JP2023545046 A5 JP 2023545046A5
Authority
JP
Japan
Prior art keywords
methyl
pyran
triazole
hydroxymethyl
deca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023521100A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023545046A (ja
JP7757399B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/077381 external-priority patent/WO2022073969A1/en
Publication of JP2023545046A publication Critical patent/JP2023545046A/ja
Publication of JP2023545046A5 publication Critical patent/JP2023545046A5/ja
Application granted granted Critical
Publication of JP7757399B2 publication Critical patent/JP7757399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023521100A 2020-10-06 2021-10-05 アルファ-d-ガラクトピラノシドのスピロ誘導体 Active JP7757399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2020077968 2020-10-06
EPPCT/EP2020/077968 2020-10-06
PCT/EP2021/077381 WO2022073969A1 (en) 2020-10-06 2021-10-05 Spiro derivatives of alpha-d-galactopyranosides

Publications (3)

Publication Number Publication Date
JP2023545046A JP2023545046A (ja) 2023-10-26
JP2023545046A5 true JP2023545046A5 (https=) 2024-10-16
JP7757399B2 JP7757399B2 (ja) 2025-10-21

Family

ID=78049262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521100A Active JP7757399B2 (ja) 2020-10-06 2021-10-05 アルファ-d-ガラクトピラノシドのスピロ誘導体

Country Status (12)

Country Link
US (1) US12312362B2 (https=)
EP (1) EP4225752B1 (https=)
JP (1) JP7757399B2 (https=)
KR (1) KR20230083301A (https=)
CN (1) CN116348463A (https=)
AU (1) AU2021356076A1 (https=)
CA (1) CA3194831A1 (https=)
ES (1) ES3014851T3 (https=)
IL (1) IL301815A (https=)
MX (1) MX2023004033A (https=)
TW (1) TWI890869B (https=)
WO (1) WO2022073969A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206893A (zh) 2019-08-09 2022-03-18 爱杜西亚药品有限公司 (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
WO2021028323A1 (en) 2019-08-09 2021-02-18 Idorsia Pharmaceuticals Ltd (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
EP4237419A1 (en) 2020-11-02 2023-09-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives
CN116806219A (zh) 2021-02-09 2023-09-26 爱杜西亚药品有限公司 羟基杂环烷-氨甲酰基衍生物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100172D0 (sv) 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
DK2906227T3 (en) 2012-10-10 2018-12-10 Galectin Therapeutics Inc GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy
CN104755088A (zh) 2012-10-31 2015-07-01 格莱克特生物技术公司 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用
EP2919802A4 (en) 2012-11-15 2016-09-14 Univ Tufts METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
CA2970062C (en) * 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
PL3456717T3 (pl) 2015-07-06 2021-10-25 Gilead Sciences, Inc. Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej
CA3025867A1 (en) 2016-07-12 2018-01-18 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
KR20200015528A (ko) 2017-05-12 2020-02-12 갈랙틴 사이언시즈, 엘엘씨 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
EP3621973A4 (en) 2017-05-12 2021-10-27 Galectin Sciences, LLC COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF
WO2019067702A1 (en) 2017-09-27 2019-04-04 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
US11072626B2 (en) 2017-10-11 2021-07-27 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3
CA3080128A1 (en) 2017-10-31 2019-05-09 Galectin Sciences, Llc Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
JP2022508720A (ja) 2018-10-15 2022-01-19 ガレクト バイオテック エービー ガレクチンのガラクトシド阻害剤
CN113286632A (zh) 2018-10-15 2021-08-20 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂前药
WO2020104335A1 (en) * 2018-11-21 2020-05-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CA3122321A1 (en) * 2018-12-27 2020-07-02 Glycomimetics, Inc. Galectin-3 inhibiting c-glycosides
US12269819B2 (en) 2019-04-10 2025-04-08 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3
JP7674276B2 (ja) 2019-07-03 2025-05-09 ガレクト バイオテック エービー ガレクチンの新規なガラクトシド阻害剤
WO2021004940A1 (en) 2019-07-05 2021-01-14 Galecto Biotech Ab Novel galactoside inhibitor of galectins
CN114206893A (zh) 2019-08-09 2022-03-18 爱杜西亚药品有限公司 (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
WO2021028323A1 (en) 2019-08-09 2021-02-18 Idorsia Pharmaceuticals Ltd (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
EP4237419A1 (en) 2020-11-02 2023-09-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives
CN116806219A (zh) 2021-02-09 2023-09-26 爱杜西亚药品有限公司 羟基杂环烷-氨甲酰基衍生物
RS67032B1 (sr) 2021-03-03 2025-08-29 Idorsia Pharmaceuticals Ltd Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom

Similar Documents

Publication Publication Date Title
JP2023545046A5 (https=)
US10980815B2 (en) Aminopyrimidinyl compounds
US11040035B2 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
JP2022546029A5 (https=)
JP2024506182A5 (https=)
JP2020519589A5 (https=)
JP7567041B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての新規な構造の化合物およびこれを含む薬剤学的組成物
JP2022534261A5 (https=)
US10214537B2 (en) Bicyclic heteroaryl amine compounds
KR102345381B1 (ko) 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물
JP2024509421A5 (https=)
JP7757399B2 (ja) アルファ-d-ガラクトピラノシドのスピロ誘導体
JP2017523223A5 (https=)
JP2023547241A5 (https=)
US11471455B2 (en) Compounds and compositions for treating conditions associated with APJ receptor activity
RU2007130153A (ru) Амидные производные
JP2018512408A5 (https=)
JP2017521399A (ja) 腎髄質外層カリウムチャンネルの阻害剤
JP2022550353A (ja) アザキノリン化合物およびその使用
CN113329748A (zh) 抑制脂肪酸合酶(fasn)
US20260053834A1 (en) Covalent modifiers of akt1 and uses thereof
RU2006133373A (ru) Производные имидазолина, обладающие св1-антагонистической активностью
KR20170021358A (ko) 신장 외수질성 칼륨 채널의 억제제
JP7101176B2 (ja) 新規JAKキナーゼ阻害剤としての5-(7H-ピロロ[2,3-d]ピリミジン-4-イル)-5-アザスピロ[2.5]オクタン-8-カルボン酸誘導体
JP2025505609A5 (https=)